Hartford Funds Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-718
Closed -$252K 99
2025
Q4
$252K Buy
718
+72
+11% +$24.3K 0.02% 94
2025
Q3
$209K Sell
646
-110
-15% -$34.2K 0.02% 94
2025
Q2
$295K Sell
756
-68
-8% -$27.4K 0.03% 96
2025
Q1
$358K Buy
+824
New +$331K 0.03% 93

Other funds holding ELV

Hartford Funds Management's ELV Position: Q1 2026 in Review

Hartford Funds Management sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 718 shares — an estimated $252K sold.

Hartford Funds Management first reported a position in ELV in Q1 2025 and held it in 4 quarters. The position peaked at $358K in Q1 2025. 1,470 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Hartford Funds Management reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
  • Hartford Funds Management sold 718 Elevance Health shares in Q1 2026, an estimated $252K.
  • Hartford Funds Management first reported a position in Elevance Health in Q1 2025 and held it in 4 quarters.
  • Hartford Funds Management's Elevance Health position peaked at $358K in Q1 2025.
  • 1,470 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Hartford Funds Management's 13F filing for Q1 2026, filed 4 May 2026.